Evergraf 0.25 mg Tablet
$6,56
$5,12
Evergraf 0.25 mg tablet is a targeted anticancer medication designed to combat advanced stages of various malignancies, including those affecting the pancreas, stomach, intestines, and lungs, particularly when surgical options are no longer viable. This innovative treatment works by inhibiting the growth of cancer cells, thereby slowing disease progression and improving patient outcomes. As with any medication, it is crucial to be aware of potential side effects and contraindications; patients should discuss their complete medical history with their healthcare provider to ensure safe usage. Regular monitoring is advised to track the drug's effectiveness and manage any adverse reactions effectively. Evergraf offers a vital option for patients facing challenging cancer diagnoses, making it an essential part of their treatment plan. Always consult your healthcare professional before starting therapy to understand how Evergraf fits into your overall cancer care strategy. With ongoing advancements in oncology, Evergraf remains a significant player in the fight against cancer, providing hope for those in need.
數量
Active Pharmaceutical Ingredient
Uses
• Evergraf 0.25 mg tablet is utilized in the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer. It is typically used in conjunction with exemestane after previous treatments with letrozole or anastrozole have failed. Patients may experience symptoms such as changes in breast appearance or unexplained weight loss. The medication aims to help manage the disease and improve quality of life.
• Evergraf 0.25 mg tablet may also play a role in the management of neuroendocrine tumors (NET), which are uncommon tumors that can develop in various organs. These tumors often originate in the lungs, appendix, or pancreas and can lead to diverse symptoms depending on their location. The use of Evergraf 0.25 mg tablet in this context is aimed at stabilizing the disease and alleviating symptoms associated with NET. This can provide significant benefits for patients facing such challenging conditions.
• In adult patients with kidney cancer, Evergraf 0.25 mg tablet is indicated after the failure of treatment with sunitinib or sorafenib. Kidney cancer can present with various symptoms, including fatigue, weight loss, and swelling. The use of Evergraf 0.25 mg tablet aims to offer another line of defense against the disease. By doing so, it helps to improve the management of this serious condition.
• Evergraf 0.25 mg tablet is also used for treating renal angiomyolipoma associated with Tuberous Sclerosis Complex (TSC) in adult patients who do not require immediate surgery. This condition is characterized by benign tumors in the kidneys that can cause complications if left untreated. By utilizing Evergraf 0.25 mg tablet, healthcare providers aim to effectively manage the growth of these tumors. This treatment option can help maintain kidney function and overall health in affected individuals.
Benefits
Evergraf 0.25 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Benefits of Evergraf 0.25 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Evergraf 0.25 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
How Evergraf 0.25 mg Tablet works may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Side effects of Evergraf 0.25 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Side effects of Evergraf 0.25 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Evergraf 0.25 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Evergraf 0.25 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Evergraf 0.25 mg. Uses of Evergraf 0.25 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Benefits of Evergraf 0.25 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Benefits of Evergraf 0.25 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Evergraf 0.25 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Evergraf 0.25 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Benefits of Evergraf 0.25 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Uses of Evergraf 0.25 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: How Evergraf 0.25 mg Tablet works may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this How Evergraf 0.25 mg Tablet works.